NDC 55150-355 – Irinotecan Hydrochloride
Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Intravenous
Product NDC55150-355
Product details
- Brand name
- Irinotecan Hydrochloride
- Generic name
- Irinotecan Hydrochloride
- Labeler
- Eugia US LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA213278
- Marketed since
- April 11, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Irinotecan Hydrochloride 20 mg/mL
Uses, dosage, side effects and warnings for Irinotecan Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55150-355-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-355-01) / 25 mL in 1 VIAL, SINGLE-DOSE | Apr 11, 2022 |
Other Irinotecan Hydrochloride products
- 45963-614 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Actavis Pharma, Inc.
- 60505-6128 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Apotex Corp.
- 60505-6272 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Apotex Corp.
- 55150-352 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-353 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-354 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 63323-193 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 61703-349 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Hospira, Inc.
- 67184-0513 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 67184-0512 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 67184-0511 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 25021-230 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Sagent Pharmaceuticals